PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25471017-0	2015	Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner.	dihydromyricetin	23-39	angiotensinogen	Rattus norvegicus	43-57	
28414055-0	2017	Dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress.	dihydromyricetin	0-16	angiotensinogen	Rattus norvegicus	28-34	
28414055-6	2017	We found that pre-incubation with DMY (20muM, 40muM, 80muM) for 4h, 12h or 24h attenuated the proliferation of cardiac fibroblasts induced by Ang II.	dihydromyricetin	34-37	angiotensinogen	Rattus norvegicus	142-148	
28414055-9	2017	DMY suppressed p22phox, while enhanced antioxidant SOD and Trx expression in Ang II stimulated cardiac fibroblasts.	dihydromyricetin	0-3	angiotensinogen	Rattus norvegicus	77-83	
28414055-10	2017	Thus, dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress.	dihydromyricetin	6-22	angiotensinogen	Rattus norvegicus	34-40	
25471017-3	2015	OBJECTIVE: To investigate whether DMY had potential therapeutic value to protect against angiotensin II (Ang II)-induced cardiomyocyte hypertrophy.	dihydromyricetin	34-37	angiotensinogen	Rattus norvegicus	89-103	
25471017-3	2015	OBJECTIVE: To investigate whether DMY had potential therapeutic value to protect against angiotensin II (Ang II)-induced cardiomyocyte hypertrophy.	dihydromyricetin	34-37	angiotensinogen	Rattus norvegicus	105-111	
25471017-13	2015	CONCLUSION: Attenuating effects of DMY on Ang II-induced cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner.	dihydromyricetin	35-38	angiotensinogen	Rattus norvegicus	42-48